Miguel Puerro Vicente-rekin lankidetzan egindako argitalpenak (2)

2021

  1. Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study

    BMC Medicine, Vol. 19, Núm. 1

2020

  1. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

    The Lancet, Vol. 395, Núm. 10238, pp. 1705-1714